ImmuneRegen News

ImmuneRegen® BioSciences Confirms Adult Stem Cell Activity of Homspera® in Human Bone Marrow
June 9, 2008

ImmuneRegen® Appoints Renowned Hematologist Ivan N. Rich, Ph.D. to Advisory Board
May 6, 2008

ImmuneRegen(R) BioSciences to Provide Adjuvant to DynPort Vaccine Company for Development of an Inactivated Vaccine against Venezuelan Equine Encephalitis Virus
April 30, 2008

ImmuneRegen(R) and BioCure Collaborate on Novel Wound-Healing Product
April 24, 2008

ImmuneRegen Releases Results from UMDNJ Study Confirming Homspera's Adult Stem Cell Activity
April 16, 2008

ImmuneRegen® BioSciences Signs Material Transfer Agreement with University of Medicine and Dentistry of New Jersey
April 1, 2008

ImmuneRegen® BioSciences Releases Study Results Showing Homspera™ Stimulates Adult Stem Cell Activity
March 27, 2008

ImmuneRegen® BioSciences and DelSite Biotechnologies Collaborate On New Flu Treatment
March 24, 2008

ImmuneRegen BioSciences Signs Lovelace Respiratory Research Institute as Development and Regulatory Partner
February 19, 2008

ImmuneRegen BioSciences Announces Material Transfer Agreement with HemoGenix(R)
January 28, 2008

ImmuneRegen BioSciences Signs Material Transfer Agreement with Celgene Cellular Therapeutics
January 23, 2008

IR BioSciences Announces $3 Million Financing Agreement
January 9, 2008

 

 

Copyright © 2003-2008, ImmuneRegen Biosciences, Inc. All rights reserved.